Researchers Seek Potential New Obesity & Type 2 Drug

GIP and GLP-1 are substances produced in the body’s digestive tract, and they play important roles in regulating body weight and food intake. A recently published study on their effects suggests that they may one day be used to develop drugs to treat obesity and type 2 diabetes. Read more

Posted in Type II Drugs